Log in
NYSE:TFX

Teleflex Stock Forecast, Price & News

$346.58
-11.32 (-3.16 %)
(As of 09/17/2020 12:00 AM ET)
Add
Compare
Today's Range
$344.74
Now: $346.58
$355.77
50-Day Range
$357.90
MA: $378.65
$408.18
52-Week Range
$221.27
Now: $346.58
$409.27
Volume371,985 shs
Average Volume252,914 shs
Market Capitalization$16.12 billion
P/E Ratio34.11
Dividend Yield0.38%
Beta1
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Read More
Teleflex logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.71 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP87936910
Phone610-225-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.60 billion
Cash Flow$15.02 per share
Book Value$64.35 per share

Profitability

Net Income$461.47 million

Miscellaneous

Employees14,400
Market Cap$16.12 billion
Next Earnings Date10/29/2020 (Estimated)
OptionableOptionable
$346.58
-11.32 (-3.16 %)
(As of 09/17/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Teleflex (NYSE:TFX) Frequently Asked Questions

How has Teleflex's stock been impacted by COVID-19?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TFX stock has increased by 1.3% and is now trading at $346.58.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Teleflex?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Teleflex
.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Teleflex
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings results on Thursday, July, 30th. The medical technology company reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.25 by $0.68. The medical technology company had revenue of $567 million for the quarter, compared to the consensus estimate of $537.85 million. Teleflex had a net margin of 18.99% and a return on equity of 17.15%. The business's revenue for the quarter was down 13.1% on a year-over-year basis. During the same quarter last year, the business posted $2.66 EPS.
View Teleflex's earnings history
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Thursday, July 30th. Investors of record on Friday, August 14th will be given a dividend of $0.34 per share on Tuesday, September 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date of this dividend is Thursday, August 13th.
View Teleflex's dividend history
.

What price target have analysts set for TFX?

10 equities research analysts have issued 12 month price targets for Teleflex's stock. Their forecasts range from $275.00 to $440.00. On average, they anticipate Teleflex's stock price to reach $389.40 in the next twelve months. This suggests a possible upside of 12.4% from the stock's current price.
View analysts' price targets for Teleflex
.

Are investors shorting Teleflex?

Teleflex saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 597,300 shares, a drop of 12.3% from the August 15th total of 681,200 shares. Based on an average daily trading volume, of 198,400 shares, the short-interest ratio is presently 3.0 days.
View Teleflex's Short Interest
.

Who are some of Teleflex's key competitors?

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), QUALCOMM (QCOM), salesforce.com (CRM), Visa (V), Cisco Systems (CSCO), JPMorgan Chase & Co. (JPM) and Lam Research (LRCX).

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Mr. Liam J. Kelly, Pres, CEO & Director (Age 52)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 57)
  • Mr. James J. Leyden, VP, Gen. Counsel & Sec. (Age 52)
  • Mr. John R. Deren, VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy, Chief Information Officer & VP

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.11%), Marshall Wace LLP (1.46%), William Blair Investment Management LLC (1.20%), Marshall Wace North America L.P. (1.20%), Bank of New York Mellon Corp (1.17%) and Bessemer Group Inc. (0.95%). Company insiders that own Teleflex stock include Benson Smith, Cameron P Hicks, James J Leyden, John C Heinmiller, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle, Thomas Anthony Kennedy and Thomas E Powell.
View institutional ownership trends for Teleflex
.

Which institutional investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including GQG Partners LLC, Goldman Sachs Group Inc., William Blair Investment Management LLC, Vanguard Group Inc., First Trust Advisors LP, Russell Investments Group Ltd., Mar Vista Investment Partners LLC, and Balyasny Asset Management LLC. Company insiders that have sold Teleflex company stock in the last year include Benson Smith, Cameron P Hicks, James J Leyden, John Deren, Stephen K MD Klasko, and Thomas E Powell.
View insider buying and selling activity for Teleflex
.

Which institutional investors are buying Teleflex stock?

TFX stock was acquired by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Bank of New York Mellon Corp, Ceredex Value Advisors LLC, Marshall Wace North America L.P., Retirement Systems of Alabama, State of Wisconsin Investment Board, State of Tennessee Treasury Department, and Principal Financial Group Inc..
View insider buying and selling activity for Teleflex
.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $346.58.

How big of a company is Teleflex?

Teleflex has a market capitalization of $16.12 billion and generates $2.60 billion in revenue each year. The medical technology company earns $461.47 million in net income (profit) each year or $11.15 on an earnings per share basis. Teleflex employs 14,400 workers across the globe.

What is Teleflex's official website?

The official website for Teleflex is www.teleflex.com.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]

This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.